Search Results | Blood | American Society of Hematology

1-20 of 45

2 3

Sort by

Sort Order Select

Journal Articles

G-CSF Upregulates the Expression of Aquaporin-9 through C/EBP-Beta to Enhance the Cytotoxic Activity of Arsenic Trioxide to Acute Myeloid Leukemia Cells

Wanbin Fu, Lan Xu, Jia Liu, Xiaofeng Han, Junying Wang, Xinpeng Wang, Huanbin Zhao, Jian Hou, Jiong Hu, Hua Zhong

Blood (2021) 138 (Supplement 1): 4338.

DOI: https://doi.org/10.1182/blood-2021-149973

Published: 2021

Journal Articles

Progression-Free Survival Outcomes By Response Status for Bortezomib, Melphalan, and Prednisone with or without Daratumumab in Newly Diagnosed Multiple Myeloma: Pooled Subgroup Analysis of Octans and Alcyone

Blood (2021) 138 (Supplement 1): 1648.

DOI: https://doi.org/10.1182/blood-2021-148937

Published: 2021

Journal Articles

Randomized Trial Comparing Pomalidomide, Bortezomib, and Dexamethasone (PVd) Versus Bortezomib and Dexamethasone（Vd） in NDMM with Renal Impairment（RI）

Jian Hou

Blood (2021) 138 (Supplement 1): 1660.

DOI: https://doi.org/10.1182/blood-2021-146914

Published: 2021

Journal Articles

Daratumumab, Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma: Pooled Analysis of Octans and Alcyone

Blood (2021) 138 (Supplement 1): 1661.

DOI: https://doi.org/10.1182/blood-2021-146974

Published: 2021

Journal Articles

Efficacy and Safety of Lenalidomide, Rituximab Combined with Second-Line Chemotherapy (R 2 -chemo) in Patients with Relapsed/Refractory Diffuse Large-B Cell Lymphoma

Fei Xiao, Honghui Huang, PhD MD, Yanni Hua, Yi Fang, Minyue Zhang, Jian Hou, PhD MD

Blood (2020) 136 (Supplement 1): 6–7.

DOI: https://doi.org/10.1182/blood-2020-141152

Published: 2020

Journal Articles

A Rare Aggressive Case of Follicular Dendritic Cell Sarcoma

Yi Fang, Fei Xiao, Jianchen Fang, Jian Hou, PhD MD, Honghui Huang, PhD MD

Blood (2020) 136 (Supplement 1): 18.

DOI: https://doi.org/10.1182/blood-2020-142259

Published: 2020

Journal Articles

The role of AGK in thrombocytopoiesis and possible therapeutic strategies

Haojie Jiang, Zhuo Yu, Nan Ding, Mina Yang, Lin Zhang, Xuemei Fan, Yuan Zhou, Qiang Zou, Jian Hou, Junke Zheng, Lei Zhang, Yanyan Xu, Junling Liu

Blood (2020) 136 (1): 119–129.

DOI: https://doi.org/10.1182/blood.2019003851

Published: 2020

Includes: Supplemental data

Journal Articles

Phase 1 Study of Bisthianostat, an Orally Efficacious Pan-HDAC Inhibitor: Part Results of Safety, Pharmacokinetics and Efficacy in Patients with Relapsed or Refractory Multiple Myeloma

Hong-Hui Huang, PhD MD, Jian Hou, PhD MD, Yang-Ming Zhang, PhD, Yu-Bo Zhou, PhD, Li Jia, PhD, Fa-Jun Nan, PhD

Blood (2019) 134 (Supplement_1): 5591.

DOI: https://doi.org/10.1182/blood-2019-129683

Published: 2019

Journal Articles

Dynamic Analysis of Cytokine Profile for Cytokine Release Syndrome in Multiple Myeloma Patients after CAR-T Cell Therapy

Shuangshuang Yang, MD, Lijuan Chen, MD PhD, Jie Xu, MD PhD, Frank Xiao-Hu Fan, MD PhD, Sun Yan, PhD, Wen Wu, MD PhD, Yan Wang, MD, Jin Wang, MD PhD, Shiwei Jin, MD, Yuebo Zhou, Yuanfang Liu, MD PhD, Yan Zhuang, PhD, Wu Zhang, PhD, Jun-Min Li, Jian Hou, PhD MD, Jian-Yong Li, MD PhD, Zhu Chen, PhD, Jian-Qing Mi, MD PhD, Sai-Juan Chen, PhD

Blood (2019) 134 (Supplement_1): 5617.

DOI: https://doi.org/10.1182/blood-2019-131799

Published: 2019

Journal Articles

Updated Phase 1 Results of a First-in-Human Open-Label Study of Lcar-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (Bcma)

Blood (2019) 134 (Supplement_1): 1858.

DOI: https://doi.org/10.1182/blood-2019-130008

Published: 2019

Journal Articles

Effective Treatment of Relapsed/Refractory Multiple Myeloma Including Extramedullary Involvement By BCMA-Specific Chimeric Antigen Receptor-Modified T Cells

Jian-Qing Mi, MD PhD, Xiaohu (Frank) Fan, PhD, Jie Xu, PhDMD, Yuanfang Liu, MD PhD, Yan Zhuang, PhD, Shuangshuang Yang, Wu Zhang, PhD, Bing Chen, MD PhD, Yueying Wang, PhD, Xiangqin Weng, Junmin Li, Weijun Fu, MD, Hua Jiang, MD, Li Zhu, Zhu Chen, PhD, Sai-Juan Chen, PhD, Jian Hou, PhD MD

Blood (2017) 130 (Supplement 1): 3115.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.3115.3115

Published: 2017

Journal Articles

C-Reactive Protein Promotes Bone Destruction in Human Myeloma By Stimulating Myeloma Cell Production of Osteolytic Cytokines Via the CD32/FcγRII-p38MAPK-Twist Axis

Jing Yang, PhD, Zhiqiang Liu, PhD, Huan Liu, PhD, Jin He, Jianling Yang, PhD, Pei Lin, MDDM,MDC, Qiang WANG, PhD, Juan Du, PhD MD, Wencai Ma, Richard E Davis, BSPharm, MS, Robert Z. Orlowski, MD PhD, Jian Hou, MD, Qing Yi, MD PhD

Blood (2017) 130 (Supplement 1): 3043.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.3043.3043

Published: 2017

Journal Articles

IgD Myeloma: Clinical Features and Outcome from a Multicenter Retrospective Study in Chinese and Korean of 308 Patients from Asian Myeloma Network (AMN) Project

Juan Du, PhD MD, Weijun Fu, MD, Jae Hoon Lee, MD PhD, Chunyang Zhang, MD, Kihyun Kim, MD, Ai Jun Liu, MD, Jin Lu, Cheolwon Suh, MD PhD, Min Kyoung Kim, MD PhD, Wenming Chen, MD, Jin Liu, Hua Jiang, MD, Jian Hou, PhD MD

Blood (2017) 130 (Supplement 1): 5409.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.5409.5409

Published: 2017

Journal Articles

Clarithromycin Interacts with Lenalidomide in the Combination Regimen Bird and Overcomes Drug Resistance in Multiple Myeloma

Fengyan Jin, MD PhD, Shuang Li, MD, Lijuan Chen, PhD, Chuan Wu, MD, Wei Li, MD, Jian Hou, MD, Yun Dai, MD PhD

Blood (2016) 128 (22): 2125.

DOI: https://doi.org/10.1182/blood.V128.22.2125.2125

Published: 2016

Journal Articles

Targeting Myeloma-Associated Macrophage Inhibits Multiple Myeloma Progression By Enhancing Anti-Tumor Cytotoxic CD4 + T Cell Response

Wang Qiang, PhD, Yong Lu, Rong Li, Zhen Cai, MD PhD, Jian Hou, MD, Siqing Wang, Qing Yi

Blood (2016) 128 (22): 481.

DOI: https://doi.org/10.1182/blood.V128.22.481.481

Published: 2016

Journal Articles

Thymidine Phosphorylase Exerts Complex Effects on Bone Resorption and Formation in Myeloma

Huan Liu, PhD, Zhiqiang Liu, PhD, Juan Du, MD, Jin He, M.S., Pei Lin, MD, Amini Behrang, MD, Michael W Starbuck, M.S., Nora M Novane, MD, Jatin J. Shah, MD, Richard Eric Davis, MD, Jian Hou, MD, Robert Gagel, MD, Jing Yang, PhD

Blood (2016) 128 (22): 1135.

DOI: https://doi.org/10.1182/blood.V128.22.1135.1135

Published: 2016

Journal Articles

The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice

Zubin Zhang, Jiefei Tong, Xiaowen Tang, Jiaxiang Juan, Biyin Cao, Rose Hurren, Guodong Chen, Paul Taylor, Xin Xu, Chang-xin Shi, Juan Du, Jian Hou, Guanghui Wang, Depei Wu, A. Keith Stewart, Aaron D. Schimmer, Michael F. Moran, Xinliang Mao

Blood (2016) 127 (13): 1676–1686.

DOI: https://doi.org/10.1182/blood-2015-07-658203

Published: 2016

Includes: Supplemental data

Journal Articles

Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment

Blood (2016) 127 (6): 713–721.

DOI: https://doi.org/10.1182/blood-2015-09-665018

Published: 2016

Includes: Supplemental data

Journal Articles

Macrofocal Multple Myeloma Is a Particular Subgroup of Multiple Myeloma

Jianling Fan, MD, Jian Hou, MD PhD, Juan Du, MD PhD, Lina Jin, Lihui Peng, Baoan Chen, PhD Professor, Hao Xi, Hui Zhang, Hua Jiang, MD, Fan Zhou, Weijun Fu, MD

Blood (2015) 126 (23): 1855.

DOI: https://doi.org/10.1182/blood.V126.23.1855.1855

Published: 2015

Journal Articles

Final Analysis of Overall Survival from the Phase 3 Panorama 1 Trial of Panobinostat Plus Bortezomib and Dexamethasone Versus Placebo Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma

Blood (2015) 126 (23): 3026.

DOI: https://doi.org/10.1182/blood.V126.23.3026.3026

Published: 2015

2 3

NARROW

G-CSF Upregulates the Expression of Aquaporin-9 through C/EBP-Beta to Enhance the Cytotoxic Activity of Arsenic Trioxide to Acute Myeloid Leukemia Cells

Progression-Free Survival Outcomes By Response Status for Bortezomib, Melphalan, and Prednisone with or without Daratumumab in Newly Diagnosed Multiple Myeloma: Pooled Subgroup Analysis of Octans and Alcyone

Randomized Trial Comparing Pomalidomide, Bortezomib, and Dexamethasone (PVd) Versus Bortezomib and Dexamethasone（Vd） in NDMM with Renal Impairment（RI）

Daratumumab, Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma: Pooled Analysis of Octans and Alcyone

Efficacy and Safety of Lenalidomide, Rituximab Combined with Second-Line Chemotherapy (R 2 -chemo) in Patients with Relapsed/Refractory Diffuse Large-B Cell Lymphoma

A Rare Aggressive Case of Follicular Dendritic Cell Sarcoma

The role of AGK in thrombocytopoiesis and possible therapeutic strategies

Phase 1 Study of Bisthianostat, an Orally Efficacious Pan-HDAC Inhibitor: Part Results of Safety, Pharmacokinetics and Efficacy in Patients with Relapsed or Refractory Multiple Myeloma

Dynamic Analysis of Cytokine Profile for Cytokine Release Syndrome in Multiple Myeloma Patients after CAR-T Cell Therapy

Updated Phase 1 Results of a First-in-Human Open-Label Study of Lcar-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (Bcma)

Effective Treatment of Relapsed/Refractory Multiple Myeloma Including Extramedullary Involvement By BCMA-Specific Chimeric Antigen Receptor-Modified T Cells

C-Reactive Protein Promotes Bone Destruction in Human Myeloma By Stimulating Myeloma Cell Production of Osteolytic Cytokines Via the CD32/FcγRII-p38MAPK-Twist Axis

IgD Myeloma: Clinical Features and Outcome from a Multicenter Retrospective Study in Chinese and Korean of 308 Patients from Asian Myeloma Network (AMN) Project

Clarithromycin Interacts with Lenalidomide in the Combination Regimen Bird and Overcomes Drug Resistance in Multiple Myeloma

Targeting Myeloma-Associated Macrophage Inhibits Multiple Myeloma Progression By Enhancing Anti-Tumor Cytotoxic CD4 + T Cell Response

Thymidine Phosphorylase Exerts Complex Effects on Bone Resorption and Formation in Myeloma

The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice

Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment

Macrofocal Multple Myeloma Is a Particular Subgroup of Multiple Myeloma

Final Analysis of Overall Survival from the Phase 3 Panorama 1 Trial of Panobinostat Plus Bortezomib and Dexamethasone Versus Placebo Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only